Veterinary Intravenous (IV) Solutions Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Veterinary Intravenous (IV) Solutions Market size will record an 8% CAGR between 2024 and 2032, on account of the increasing burden of chronic and acute diseases in animals, such as diabetes, kidney disease, and infections. As per Oak Forest Veterinary Hospital, diabetes affects 1 in every 200 cats and 1 in every 500 dogs during their lifetime. Surging R and D investments for driving innovations and the emergence of new products and formulations to address evolving needs in veterinary care will also boost market growth.

The IV solutions industry is segmented into product, indication, animal type, end-user, and region.

By indication, the industry value from the anthrax segment will record a lucrative growth rate through 2032. IV solutions offer precise monitoring and adjustment of fluid and electrolyte levels based on the patient's condition. This is particularly important in severe cases of anthrax, where the patient's needs can change rapidly. As anthrax can lead to respiratory distress, organ failure, or septic shock, IV fluids, and medications are used to manage these complications to provide vital support for the affected organs and systems.

With respect to end-user, the veterinary intravenous solutions market size from the research institutes segment will record expansion between 2024 and 2032. Veterinary IV solutions are used in educational settings to train students and professionals in the proper techniques to administer intravenous fluids and medications. This hands-on experience is vital for developing skills in veterinary care. Growing presence in critical care and emergency interventions across research settings will also boost segment growth.

Europe IV solutions industry size will register immense growth through 2032 due to the strong emphasis on improving safety and reducing the risk of infections. As patients increasingly prefer receiving care in familiar and comfortable settings, the demand for portable and user-friendly IV solutions is surging in the region. This trend is largely fueled by the growing emphasis on home healthcare and outpatient services.

Product Code: 10452

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of animal diseases
  - 3.2.1.2 Increasing animal healthcare expenditure
  - 3.2.1.3 Rising adoption of pet insurance
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Shortage of trained veterinary professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Isotonic crystalloids
5.3 Dextrose solutions
5.4 Synthetic colloids
5.5 Natural colloids
5.6 Parenteral nutrition

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Diabetic ketoacidosis
6.3 Pancreatitis
6.4 Anthrax
6.5 Chronic kidney disease
6.6 Nutritional support
6.7 Other indications

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Companion animals
7.3 Production animals

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Veterinary hospitals and clinics
8.3 Research institutes
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 B. Braun Melsungen AG
10.2 Ceva Sante Animale
10.3 Dechra Pharmaceuticals plc
10.4 Elanco Animal Health
10.5 Fresenius Kabi
10.6 Hospira (Pfizer Inc.)
10.7 Jorgensen Laboratories, LLC
10.8 Merck and Co. Inc.
10.9 Sykes Vet International Pty Ltd.
10.10 Zoetis, Inc.